Ibrutinib Capsule is prescribed for mantle-cell lymphoma and chronic lymphocytic leukemia, including cases that have undergone at least one prior therapy. The duration of treatment depends on your response, with the doctor conducting regular blood tests to monitor blood cell counts, as the medication can decrease cell numbers, potentially heightening susceptibility to infections. Common side effects include headache, diarrhea, and nausea.